Trial Profile
Vorinostat With 131-I MIBG Therapy for Resistant/Relapsed Neuroblastoma: A Phase I Study IND# 105,744
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Vorinostat (Primary) ; Filgrastim
- Indications Neuroblastoma
- Focus Adverse reactions
- 27 Oct 2015 New trial record